FindTrial
Sign In

Comparison of embryo euploidy rates between luteal-phase stimulation protocol and GnRH antagonist protocol

Comparison of embryo euploidy rates between luteal-phase stimulation protocol and GnRH antagonist protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099075
Enrollment
Unknown
Registered
2025-03-18
Start date
2024-03-20
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility

Interventions

luteal-phase stimulation group:None
conventional GnRH antagonist group:None

Sponsors

The international peace maternity and child health hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.2020.1-2023.6 Patients undergoing PGT-A in women and infants in China; 2.Only the patient’s first 3 cycles were included;

Exclusion criteria

Exclusion criteria: 1.age at retrieval > 45 years; 2.menstrual cycle disorder with antral follicle count in both ovaries >= 20; 3.FSH>15 IU/L; 4.patients indicated for preimplantation genetic testing for structural rearrangement or preimplantation genetic testing for monogenic disorder, such as parental abnormal karyotype or being diagnosed with monogenic disease; 5.core data missing; 6.repeated cycle;

Design outcomes

Primary

MeasureTime frame
euploidy rate;—

Secondary

MeasureTime frame
clinical pregnancy rate;—

Countries

China

Contacts

Public ContactWen Li

The international peace maternity and child health hospital

lyyliwen@sina.com+86 21 64474627

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026